theory clinical_55_2
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  PALBPALB2 :: "entity ⇒ bool"
  BindingPartner :: "entity ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  DNA_DamageSites :: "entity ⇒ bool"
  HRRepair :: "entity ⇒ bool"
  DNA_Damage :: "entity ⇒ bool"
  Encodes :: "event ⇒ bool"
  Localises :: "event ⇒ bool"
  Links :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  PatientEvent :: "event ⇒ entity ⇒ bool"  (* Renamed to avoid clash *)
  To :: "entity ⇒ entity ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  RepairMolecules :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Joining :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Promotes :: "event ⇒ bool"
  LossPALB2 :: "entity ⇒ bool"
  Localisation :: "event ⇒ bool"
  HRR :: "entity ⇒ bool"
  Disrupts :: "event ⇒ bool"
  Prevents :: "event ⇒ event ⇒ bool"
  Action :: "event ⇒ bool"
  Promoting :: "event ⇒ bool"  (* Added to resolve the introduced fixed type variable error *)

(* Explanation 1: Patient with a pathogenic mutation in PALBPALB2 encodes a binding partner that localises BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage. *)
axiomatization where
  explanation_1: "∃x y z w v u t e1 e2 e3. Patient x ∧ Mutation y ∧ PALBPALB2 y ∧ BindingPartner z ∧ BRCA2 w ∧ DNA_DamageSites v ∧ HRRepair u ∧ DNA_Damage t ∧ Encodes e1 ∧ Agent e1 x ∧ PatientEvent e1 z ∧ Localises e2 ∧ Agent e2 z ∧ PatientEvent e2 w ∧ To w v ∧ Links e3 ∧ Agent e3 z ∧ PatientEvent e3 w ∧ In e3 u ∧ In e3 t"

(* Explanation 2: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. BRCA2 x ∧ RepairMolecules y ∧ RAD51 z ∧ Humans w ∧ Joining e1 ∧ Agent e1 x ∧ PatientEvent e1 y ∧ Via e1 z ∧ In e1 w ∧ Promotes e2 ∧ Agent e2 x ∧ PatientEvent e2 y"

(* Explanation 3: Loss of PALB2 disrupts the localisation of BRCA2 to sites of DNA damage, preventing BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
axiomatization where
  explanation_3: "∀x y z w v e1 e2 e3 e4. LossPALB2 x ∧ Localisation e1 ∧ BRCA2 y ∧ DNA_DamageSites z ∧ RepairMolecules w ∧ HRR v ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 w ∧ In e2 v ∧ Promoting e3 ∧ Agent e3 y ∧ PatientEvent e3 w ∧ Disrupts e4 ∧ Agent e4 x ∧ PatientEvent e4 e1 ∧ Prevents e4 e3"

theorem hypothesis:
  assumes asm: "LossPALB2 x ∧ BRCA2 y ∧ RepairMolecules z"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
  shows "∀x y z e1 e2. LossPALB2 x ∧ Action e1 ∧ BRCA2 y ∧ RepairMolecules z ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 z ⟶ Prevents e1 e2"
proof -
  (* From the premise, we have the known information about LossPALB2, BRCA2, and RepairMolecules. *)
  from asm have "LossPALB2 x ∧ BRCA2 y ∧ RepairMolecules z" <ATP>
  (* Explanation 3 provides the logical relation Implies(E, F), which states that loss of PALB2 disrupts the localisation of BRCA2 to sites of DNA damage, preventing BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
  (* We can use this to infer that the loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR. *)
  then have "∀e1 e2. LossPALB2 x ∧ Action e1 ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 z ⟶ Prevents e1 e2" <ATP>
  then show ?thesis <ATP>
qed

end
